Posted by Michael Wonder on 04 Jun 2024
Mounjaro is second obesity drug to be approved for use in England
4 June 2024 - Those with BMI of at least 35 kg.m2 and a co-morbidity can now be prescribed tirzepatide and NICE says it is more effective than Wegovy.
The medical treatment regulator for England has approved a second drug to combat obesity, giving patients and doctors what it says is a more effective alternative to semaglutide.
